Search

everythinglearnresearchcommunity

for

Search:↓

PFS affects some women, steroids easily bought online, hypogonadism info unreliable, low testosterone linked to CVD.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Finasteride's potential harms are hard to accurately measure.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Corporate social responsibility can improve consumer ratings of product performance, especially when the company is seen as benevolent and consumers aren't experts on the product.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Follicular Unit Transplantation is an effective and safe treatment for hair loss due to scarring.

The G60S Connexin43 mutation causes hair growth issues and poor hair quality in mice, similar to human ODDD patients.